Company No: 11170289 (England and Wales)

Contents

• Statement of Financial Position
• Notes to the Financial Statements

	Note	2024		2023
		£		£
Fixed assets
Tangible assets	3	204		305
Investments	4	5,392,293		4,527,778
		5,392,497		4,528,083
Current assets
Debtors	5	102		1,008
Cash at bank and in hand		121,895		140,733
		121,997		141,741
Creditors: amounts falling due within one year	6	( 6,600)		( 6,600)
Net current assets		115,397		135,141
Total assets less current liabilities		5,507,894		4,663,224
Creditors: amounts falling due after more than one year	7	( 535,084)		( 973,150)
Net assets		4,972,810		3,690,074
Capital and reserves
Called-up share capital	8	226		199
Share premium account		5,220,073		4,221,719
Other reserves		132,843		30,670
Profit and loss account		( 380,332 )		( 562,514 )
Total shareholders' funds		4,972,810		3,690,074

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Comprehensive Income has not been delivered.

The financial statements of Agamon Technologies Limited (registered number: 11170289) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

M Meiri Director

16 December 2025

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Agamon Technologies Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 35 Ballards Lane, London, N3 1XW, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

The principal activity of the company was that of providing patient management systems for healthcare providers.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the Company as an individual entity and not about its group.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Statement of Financial Position date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Comprehensive Income in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment

33 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans to and from related parties.

Financial assets
Basic financial assets, including trade and other debtors, and amounts due from related companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.
At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Comprehensive Income.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Investments
Investments in non-convertible preference shares and non-puttable ordinary or preference shares (where shares are publicly traded or their fair value is reliably measurable) are measured at fair value through the Statement of Comprehensive Income. Where fair value cannot be measured reliably, investments are measured at cost less impairment.

Convertible loan notes
The component parts of compound instruments issued by the company are classified separately as financial liabilities and equity in accordance with the substance of the contractual arrangement. On initial recognition, the financial liability component is recorded at its fair value. At the date of issue, in the case of a convertible bond denominated in the functional currency of the issuer that may be converted into a fixed number of equity shares, the fair value of the liability component is estimated using the prevailing market interest rate for a similar non-convertible instrument. The equity component is determined by deducting the amount of the liability component from the fair value of the compound instrument as a whole. This is recognised and included in the equity reserve within equity and is not subsequently remeasured.

Transaction costs are apportioned between the liability and equity components of the convertible instrument based on their relative fair values at the date of issue. The portion relating to the equity component is charged directly against equity.

2. Employees

	2024		2023
	Number		Number
Monthly average number of persons employed by the company during the year, including directors	3		3

3. Tangible assets

	Computer equipment		Total
	£		£
Cost
At 01 January 2024	2,399		2,399
At 31 December 2024	2,399		2,399
Accumulated depreciation
At 01 January 2024	2,094		2,094
Charge for the financial year	101		101
At 31 December 2024	2,195		2,195
Net book value
At 31 December 2024	204		204
At 31 December 2023	305		305

4. Fixed asset investments

	2024		2023
	£		£
Subsidiary undertakings	1,077,111		772,588
Other investments and loans	4,315,182		3,755,190
	5,392,293		4,527,778

Investments in subsidiaries

	2024
	£
Cost
At 01 January 2024	772,588
Additions	304,523
At 31 December 2024	1,077,111
Carrying value at 31 December 2024	1,077,111
Carrying value at 31 December 2023	772,588

	Loans		Total
	£		£
Cost or valuation before impairment
At 01 January 2024	3,755,190		3,755,190
Additions	562,192		562,192
At 31 December 2024	4,317,382		4,317,382
Provisions for impairment
At 01 January 2024	0		0
Foreign exchange difference	2,200		2,200
At 31 December 2024	2,200		2,200
Carrying value at 31 December 2024	4,315,182		4,315,182
Carrying value at 31 December 2023	3,755,190		3,755,190

5. Debtors

	2024		2023
	£		£
Trade debtors	0		924
Prepayments	102		84
	102		1,008

6. Creditors: amounts falling due within one year

	2024		2023
	£		£
Accruals	6,600		6,600

7. Creditors: amounts falling due after more than one year

	2024		2023
	£		£
Other creditors	535,084		973,150

8. Called-up share capital

	2024		2023
	£		£
Allotted, called-up and fully-paid
782,323 Ordinary shares of £ 0.0001 each (2023: 755,715 shares of £ 0.0001 each)	78.23		75.57
93,259 Deferred ordinary shares of £ 0.0001 each	9.33		9.33
1,381,605 Series Seed ordinary shares of £ 0.0001 each (2023: 1,132,842 shares of £ 0.0001 each)	138.16		113.28
	225.72		198.18

During the year, an additional 26,608 Ordinary Shares were issued at a nominal value of £0.0001.
Further, an additional 248,763 Series Seed ordinary shares were issued at a nominal value of £0.0001.